BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.150
+0.030 (2.68%)
At close: May 12, 2025, 4:00 PM
1.169
+0.019 (1.69%)
After-hours: May 12, 2025, 7:48 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $21.22 million as of May 12, 2025. Its market cap has increased by 5.05% in one year.
Market Cap
21.22M
Enterprise Value
-2.80M
1-Year Change
5.05%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $21.22M, a decrease of -59.19%. That is a compound annual growth rate of -17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 20.70M | -41.69% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |